
Qualio is a unified quality and compliance platform that helps growing life sciences companies scale faster while staying continuously audit- and inspection-ready. Medical device, digital health, biotech, and pharma teams use Qualio to replace manual processes and disconnected tools with a single source of truth for quality, regulatory readiness, and risk.
With a modern eQMS at the foundation and Compliance Intelligence layered on top, Qualio moves teams beyond point-in-time audits. Automated gap analysis, cross-standard evidence mapping, and real-time readiness dashboards provide confidence that the organization is prepared today—not just when auditors arrive.
Qualio centralizes document control, training, CAPA, change management, supplier quality, and design controls, linking them directly to regulatory requirements and product lifecycle data. Executive-ready views show compliance health by standard, region, and product, turning regulatory readiness into a measurable business capability instead of a black box.
Compliance Intelligence continuously monitors for risk, highlights gaps early, and prioritizes remediation so teams focus effort where it matters most. Pre-validated regulatory frameworks are maintained as requirements evolve, reducing reliance on consultants and avoiding duplicate work as companies expand.
The result is faster market entry, lower compliance cost, reduced risk of findings or recalls, and confident, risk-managed growth.
Learn more

Revaly is built to solve one of the most costly and overlooked problems in subscription commerce: legitimate payments failing for preventable reasons. Its end-to-end Payment Performance Management platform leverages machine learning, issuer intelligence, and ecosystem data to elevate approval rates starting from the very first transaction attempt. The system automatically detects issues such as mistyped card numbers, routing mismatches, and metadata errors before a customer ever checks out. When payments do fail, Revaly uses a sophisticated retry engine that studies customer behavior, card network patterns, and historical success windows to recover revenue without damaging relationships. Businesses across industries report dramatic improvements—from 34% to over 50% increases in recovered payments—demonstrating the compound value of consistent, optimized approvals. Revaly’s integration ecosystem makes adoption frictionless, connecting seamlessly with CRMs, billing systems, payment gateways, and processors already in use. The platform not only protects revenue but stabilizes growth by reducing churn that comes from unintentional payment failures. Leadership teams gain visibility into payment performance metrics that go far beyond authorization rates, revealing hidden revenue opportunities and operational inefficiencies. As a result, companies can build smarter billing strategies and deliver a more reliable experience for customers. Revaly becomes a trusted partner in improving profitability, ensuring that when a customer says “yes,” the payment system does too.
Learn more
Redica
Redica is an advanced intelligence cloud platform purpose-built for quality and regulatory teams across the life sciences sector. It addresses the growing complexity of global regulations by transforming vast amounts of compliance data into proactive, decision-ready intelligence. The platform unifies regulatory updates, inspection findings, supplier quality data, and post-market signals in one centralized system. With explainable AI, Redica enables teams to track regulatory changes, understand implications, and take compliant action with confidence. Its inspection intelligence tools help organizations predict outcomes, prepare faster, and benchmark against global inspection trends. Redica also delivers site and supply chain intelligence, offering a 360-degree view of manufacturing and supplier risk. Dynamic risk scoring and red flag alerts allow teams to identify issues before they escalate. Post-market intelligence further supports safety monitoring by detecting trends across recalls, complaints, and enforcement data. By eliminating fragmented workflows and manual tracking, Redica significantly reduces response times. Seamless integrations with platforms like Veeva RIMS enhance collaboration across regulatory and quality teams. Trusted by leading pharmaceutical and biotech companies, Redica helps organizations reduce deviations and costly compliance findings. Overall, the platform empowers teams to move from reactive compliance management to proactive risk prevention.
Learn more
CoVigilAI
CoVigilAI represents a state-of-the-art innovation in the realm of medical literature monitoring, harnessing the power of artificial intelligence and advanced data analytics to proactively detect and manage adverse drug reactions, ensuring patient safety and compliance with regulatory requirements in real-time. This platform facilitates the efficient tracking of scientific and medical literature by retrieving data from prominent global databases such as PubMed and Embase, and it offers customizable search options that improve the pharmacovigilance literature review process. Furthermore, it conducts thorough evaluations of scientific articles and publications from various regional journals, guaranteeing an extensive oversight of both global and localized literature. With the implementation of sophisticated algorithms, the system categorizes Individual Case Safety Reports (ICSRs) into three distinct classifications: valid, potential, and invalid cases, while its automated key entity recognition feature proficiently pinpoints critical components such as patients, medications, adverse reactions, and pertinent medical events. This comprehensive strategy not only streamlines the monitoring procedure but also considerably boosts the precision and efficiency of drug safety evaluations, contributing to a safer healthcare environment. Ultimately, CoVigilAI serves as an indispensable tool for enhancing drug safety and fostering informed decision-making in the medical field.
Learn more